Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06152328
Recruiting Not applicable

Virtual Reality Based Mirror Therapy

NCT06152328 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-04-01
Last updated
2026-05-07

Condition(s) studied

StrokeUpper Extremity ParesisUpper Extremity Paralysis

Investigational drug(s) / intervention(s)

Virtual reality applications based on mirror therapyConventional treatmentMirror therapyPlacebo virtual reality

Virtual reality applications based on mirror therapy: Mirror therapy-based games will be played for 30 minutes every day for eight weeks, three days a week, for the VR group.

Conventional treatment: Bobath therapy, walking exercises, upper extremity active exercises, and proprioceptive neuromuscular facilitation techniques will be applied three days a week for eight weeks.

Mirror therapy: In conventional mirror therapy, the unaffected extremities of the individuals will be positioned outside the mirror, while the affected extremities will be placed inside the mirror so that the patient cannot see them. In this way, the image of the intact hand will be transferred to the affected side and activities will be performed three days a week for eight weeks.

Placebo virtual reality: For 8 weeks, watching the uninteractive virtual environment

Study summary

The aim of this study is to examine the effectiveness of 3D virtual reality assisted mirror therapy based rehabilitation applications compared to classical methods used in stroke rehabilitation.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Have a ischemic stroke * Stroke duration not less than 2 months and not more than 6 months * Individuals with a score of 2b and 3 according to the Thrombolysis in cerebral infarction (TICI) scale * A score of 2 and above according to the upper extremity motor assessment of the NIH stroke scale * Intact depth perception in the Titmus Stereopsis assessment * A score of 24 and above in the Mini-mental test and * Independent sitting balance Exclusion Criteria: * Additional neurologic diseases * Have a head injury * Have a brain tumor * Prior cranial surgery * Psychological disorder or mental problem * Previous stroke * Aphasia and apraxia * Upper extremity amputation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Abant Izzet Baysal University Faculty of Health Science Bolu Merkez Recruiting

More Abant Izzet Baysal University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06152328 on ClinicalTrials.gov ↗ ← All trials in Turkey